KYLE DONALD J has a total of 13 patent applications. Its first patent ever was published in 2008. It filed its patents most often in United States. Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and measurement are 55PHARMA DRUG DISCOVERY & DEV AG, EPIGEN BIOSCIENCES INC and EXELIXIS PATENT CO LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 13 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Organic chemistry methods | |
#5 | Analysing materials | |
#6 | Microorganisms | |
#7 | Special acyclic compounds | |
#8 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Kyle Donald J | 13 |
#2 | Tafesse Laykea | 8 |
#3 | Sun Qun | 4 |
#4 | Yao Jiangchao | 2 |
#5 | Zhou Xiaoming | 2 |
#6 | Ni Chiyou | 2 |
#7 | Soltis Daniel A | 1 |
#8 | Tussey Lynda G | 1 |
#9 | Zhang Chongwu | 1 |
#10 | Park Minnie | 1 |
Publication | Filing date | Title |
---|---|---|
US2013296281A1 | Aryl substituted indoles and their use as blockers of sodium channels | |
US2010137306A1 | Heterocyclic TRPV1 receptor ligands | |
US2010120862A1 | Monocyclic compounds and their use as TRPV1 ligands | |
US2010063030A1 | Benzenesulfonyl compounds and the use thereof |